Virtus ETF Advisers LLC Rubius Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.79 - $5.98 $9,521 - $72,070	-12,052 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.25 - $10.4 $3,064 - $7,498	-721 Reduced 5.64%	12,052 $66,000
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $51,255 - $93,933	5,295 Added 70.81%	12,773 $124,000
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $6,864 - $10,104	-390 Reduced 4.96%	7,478 $134,000
Q2 2021 Aug 10, 2021	SELL	$22.26 - $28.43 $590,513 - $754,191	-26,528 Reduced 77.13%	7,868 $192,000
Q1 2021 May 17, 2021	BUY	$8.02 - $32.01 $4,836 - $19,302	603 Added 1.78%	34,396 $911,000
Q4 2020 Feb 12, 2021	SELL	$4.23 - $8.73 $72,206 - $149,021	-17,070 Reduced 33.56%	33,793 $256,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $6.25 $32,224 - $43,312	-6,930 Reduced 11.99%	50,863 $255,000
Q2 2020 Aug 05, 2020	BUY	$4.01 - $6.88 $231,749 - $397,615	57,793 New	57,793 $346,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.